scholarly journals Assessment of Knowledge regarding Polycystic Ovary Syndrome (PCOS) among Nursing Students

2021 ◽  
Vol 07 (03) ◽  
pp. 42-45
Author(s):  
Saliqua Sehar ◽  
Keyword(s):  
Nursing Students ◽  
Polycystic Ovary Syndrome ◽  
Quantitative Research ◽  
Polycystic Ovary ◽  
Communicable Disease ◽  
Study Data ◽  
Research Approach ◽  
Ovary Syndrome ◽  
Online Mode ◽  
Health Complications

Introduction:PCOS is most common non-communicable disease in females after hypertension and diabetes mellitus in India. Females with PCOS have a higher risk of developing health complications like infertility, HTN, abortion, insulin resistance etc. Lack of knowledge and poor lifestyle choices are considered to be the major factor leading to this syndrome. Nurses are in unique position to create awareness regarding this syndrome. Informed choices and lifestyle management like weight loss ,stress management are key factors in management of this disease. Objectives:The objective of the study was to assess the knowledge regarding PCOS (Polycystic Ovary Syndrome) among Nursing Students. Methodology: The present study has used Quantitative Research Approach and Descriptive Research Design. A total 60 nursing students who were studying in DGNM 3rd year and B.Sc. Hons Nursing 4th year participated in the study. Data was gathered using demographic sheet and structured questionnaire which was administered through online mode after formal permission. Descriptive statistics such as frequency, percentage, means and median and standard deviation were used to describe the demographic profile and level of knowledge regarding PCOS. Result:The study found that majority of Nursing Students (60%) have average knowledge, 38.33% have Good knowledge and 1.66% have poor knowledge regarding Polycystic Ovary Syndrome. Conclusion:The finding of the study indicates that the majority of the Nursing students had average knowledge regarding Polycystic Ovary Syndrome (PCOS).

CLINICAL PROFILE OF YOUNG ADULTS (18-24 YEARS) WITH POLYCYSTIC OVARY SYNDROME

2021 ◽  
pp. 1-3
Author(s):  
Sheila Balakrishnan ◽  
MKC Nair ◽  
Babu George ◽  
Jaysree L ◽  
Leena ML
Keyword(s):  
Young Adults ◽  
Nursing Students ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Overweight And Obesity ◽  
Study Group ◽  
Continuous Variables ◽  
Ovary Syndrome ◽  
Chi Square ◽  
Chi Square Test

Background: Polycystic Ovary Syndrome is a common endocrine problem with a heterogenous clinical picture. Early identication is essential to prevent metabolic problems and infertility. To estimate the prevalence of Objective: Polycystic Ovary Syndrome and depict the clinical prole of young adults (18-24 years) with Polycystic Ovary syndrome. A cross- Methods: sectional study of all the nursing students aged 18-24 years in Thiruvananthapuram District was conducted to self-screen for Polycystic Ovary Syndrome and Rotterdam criteria were applied. The study group comprised 529 subjects who were diagnosed to have the syndrome. The clinical and ultrasonographic characteristics and anthropometric variables of the study group were estimated and compared with 399 young adults without Polycystic Ovary Syndrome. Variables were expressed in terms of frequenci Statistical Analyses: es for categorical and mean (± SD) for continuous variables. Chi-square test was used for categorical and t- test for continuous variables. The prevalence of Polycystic Ovary Results: Syndrome was 13.1%. Irregular periods was seen in 74.7%, hirsutism in 57.1%, acne in 37.1%, acanthosis nigricans in 51% and alopecia in 2.5%. Overweight and obesity were found in 30.8%, increased waist circumference in 16.1% and hypertension in 27.8%. Polycystic Conclusion: Ovary Syndrome is a clinically heterogenous condition with an increased prevalence of irregular periods, hirsutism, acne and acanthosis. Overweight and obesity are signicantly increased. A younger age group of late adolescents or young adults is ideal to screen for the syndrome and institute lifestyle intervention to prevent metabolic problems.

scholarly journals Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood

BMC Medicine ◽  
2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Chau Thien Tay ◽  
Roger J. Hart ◽  
Martha Hickey ◽  
Lisa J. Moran ◽  
Arul Earnest ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Polycystic Ovary Syndrome ◽  
Body Mass ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Cross Sectional ◽  
Bmi Trajectories ◽  
Health Complications ◽  
Rotterdam Criteria

Abstract Background Polycystic ovary syndrome (PCOS) is challenging to diagnose. While the 2003 Rotterdam criteria are widely used for adults, the 2018 international PCOS guideline recommended updated Rotterdam criteria with both hyperandrogenism and oligo-anovulation for adolescents based on evidence-informed expert consensus. This study compared the prevalence of PCOS using updated and original Rotterdam criteria in community-based adolescents and explored long-term body mass index (BMI) trajectories across different diagnostic phenotypes. Methods Overall, 227 postmenarchal adolescent females from the prospective cohort Raine Study undertook comprehensive PCOS assessment at age 14–16 years. Detailed anthropometric measurements were collected from birth until age 22 years. Cross-sectional and longitudinal BMI were analyzed using t tests and generalized estimating equations. Results PCOS was diagnosed in 66 (29.1%) participants using original criteria versus 37 (16.3%) participants using updated Rotterdam criteria. Using updated criteria, participants with PCOS had higher BMI than participants without PCOS from prepubertal. Only the phenotype meeting the updated criteria was significantly associated with higher long-term BMI gain whereas other PCOS phenotypes had similar BMI trajectories to participants without PCOS (p < 0.001). Conclusions The use of the 2018 updated Rotterdam criteria reduces over-diagnosis of PCOS in adolescents and identifies those at the greatest risk of long-term weight gain, a key contributor to disease severity and long-term health implications. The BMI trajectories of females with PCOS on updated criteria diverge prepubertally compared to those without PCOS. This work supports targeting adolescents diagnosed with PCOS on the 2018 updated criteria for early lifestyle interventions to prevent long-term health complications.

The role of vitamin D in metabolic and reproductive disturbances of polycystic ovary syndrome: A narrative mini-review

2020 ◽  
pp. 1-8
Author(s):  
Daniela Menichini ◽  
Gianpiero Forte ◽  
Beatrice Orrù ◽  
Giuseppe Gullo ◽  
Vittorio Unfer ◽  
...  
Keyword(s):  
Vitamin D ◽  
Polycystic Ovary Syndrome ◽  
Embryo Quality ◽  
Polycystic Ovary ◽  
Vitamin D Supplementation ◽  
Endometrial Receptivity ◽  
Metabolic Disturbances ◽  
Ovary Syndrome ◽  
Beneficial Role

Abstract. Vitamin D is a secosteroid hormone that plays a pivotal role in several metabolic and reproductive pathways in humans. Increasing evidence supports the role of vitamin D deficiency in metabolic disturbances and infertility in women with polycystic ovary syndrome (PCOS). Indeed, supplementation with vitamin D seems to have a beneficial role on insulin resistance and endometrial receptivity. On the other hand, exceedingly high levels of vitamin D appear to play a detrimental role on oocytes development and embryo quality. In the current review, we summarize the available evidence about the topic, aiming to suggest the best supplementation strategy in women with PCOS or, more generally, in those with metabolic disturbances and infertility. Based on the retrieved data, vitamin D seems to have a beneficial role on IR, insulin sensitivity and endometrial receptivity, but high levels and incorrect timing of administration seem to have a detrimental role on oocytes development and embryo quality. Therefore, we encourage a low dose supplementation (400–800 IU/day) particularly in vitamin D deficient women that present metabolic disturbances like PCOS. As far as the reproductive health, we advise vitamin D supplementation in selected populations, only during specific moments of the ovarian cycle, to support the luteal phase. However, ambiguities about dosage and timing of the supplementation still emerge from the clinical studies published to date and further studies are required.

Metformin Treatment Ameliorates Liver Injury Indicating Fatty Liver Polycystic Ovary Syndrome

2015 ◽  
Vol 53 (01) ◽  
Author(s):  
S Tan ◽  
N Vollmar ◽  
S Benson ◽  
LP Bechmann ◽  
G Gerken ◽  
...  
Keyword(s):  
Liver Injury ◽  
Polycystic Ovary Syndrome ◽  
Fatty Liver ◽  
Polycystic Ovary ◽  
Metformin Treatment ◽  
Ovary Syndrome
Sign in / Sign up

Export Citation Format

Share Document